These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 184313)

  • 1. [Present status and prospects of platelet inhibitors].
    Yasunaga K
    Rinsho Ketsueki; 1976 Jun; 17(6):590-9. PubMed ID: 184313
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
    Zahavi M; Zahavi J; Kakkar VV
    Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of separated forms of human platelet cyclic nucleotide phosphodiesterase by platelet aggregation inhibitors.
    Asano T; Ochiai Y; Hidaka H
    Mol Pharmacol; 1977 May; 13(3):400-6. PubMed ID: 195193
    [No Abstract]   [Full Text] [Related]  

  • 4. Roles of cyclic nucleotides in platelet function.
    Haslam RJ
    Ciba Found Symp; 1975; 35():121-51. PubMed ID: 179765
    [No Abstract]   [Full Text] [Related]  

  • 5. The influence of prostaglandin G2 on platelet ultrastructure and platelet secretion.
    Gerrard JM; Townsend D; Stoddard S; Witkop CJ; White JG
    Am J Pathol; 1977 Jan; 86(1):99-116. PubMed ID: 188341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cyclic adenosine monophosphate, prostaglandin E and aggregation of blood platelets in man].
    Ardelt W
    Fortschr Med; 1977 Feb; 95(6):366-70. PubMed ID: 190100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of blood platelet function by cyclic nucleotides.
    Haslam RJ; Davidson MM; Davies T; Lynham JA; McClenaghan MD
    Adv Cyclic Nucleotide Res; 1978; 9():533-52. PubMed ID: 208396
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclic nucleotides in hypertension.
    Hamet P; Franks DJ; Adnot S; Coquil JF
    Adv Cyclic Nucleotide Res; 1980; 12():11-23. PubMed ID: 6250345
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclic AMP inhibits synthesis of prostaglandin endoperoxide (PGG2) in human platelets.
    Malmsten C; Granström E; Samuelsson B
    Biochem Biophys Res Commun; 1976 Jan; 68(2):569-76. PubMed ID: 175797
    [No Abstract]   [Full Text] [Related]  

  • 10. Some characteristics of mouse platelet aggregation and a comparison of the activity of a range of compounds in mouse and human platelet-rich plasma in vitro.
    Nunn B
    Thromb Haemost; 1981 Feb; 45(1):1-5. PubMed ID: 7245119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The involvement of prostaglandin endoperoxide formation in the elevation of cyclic GMP levels during platelet aggregation.
    Glass DB; Gerrard JM; Townsend D; Carr DW; White JG; Goldberg ND
    J Cyclic Nucleotide Res; 1977 Feb; 3(1):37-44. PubMed ID: 191476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of prostaglandins and drotaverine on ADP-induced platelet aggregation.
    Losonczy H; Nagy I; Gregus Z
    Acta Med Acad Sci Hung; 1974; 31(3-4):157-63. PubMed ID: 4469713
    [No Abstract]   [Full Text] [Related]  

  • 13. Effet of prostaglandin E1 alone and in combination with theophylline or aspirin on collagen-induced platelet aggregation and on platelet nucleotides including adenosine 3':5'-cyclic monophosphate.
    Ball G; Brereton GG; Fulwood M; Ireland DM; Yates P
    Biochem J; 1970 Dec; 120(4):709-18. PubMed ID: 4322038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic nucleotides in hemostasis and thrombosis.
    Steer ML; Salzman EW
    Adv Cyclic Nucleotide Res; 1980; 12():71-92. PubMed ID: 6250376
    [No Abstract]   [Full Text] [Related]  

  • 15. [Platelet suppressive drugs (author's transl)].
    Shio H; Kameyama M
    No Shinkei Geka; 1981 Feb; 9(2):113-22. PubMed ID: 6264335
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the role of cyclic 3',5'-adenosine monophosphate in platelet functions with special reference to aggregation and serotonin release of human blood platelets.
    Ryo R
    Nihon Ketsueki Gakkai Zasshi; 1976 Feb; 39(1):85-96. PubMed ID: 183445
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of antiplatelet agents on platelets exposed to shear stress.
    Hardwick RA; Hellums JD; Moake JL; Peterson DM; Alfrey CP
    Trans Am Soc Artif Intern Organs; 1980; 26():179-84. PubMed ID: 7245479
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of acetylsalicylic acid and prostaglandin on posttraumatic pulmonary platelet sequestration.
    Thörne LJ; Kuenzig M; Schwartz SI
    Surg Forum; 1979; 30():175-7. PubMed ID: 538587
    [No Abstract]   [Full Text] [Related]  

  • 19. Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin.
    Moncada S; Korbut R
    Lancet; 1978 Jun; 1(8077):1286-9. PubMed ID: 78050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of prostaglandins, derivatives of cyclic 3':5'-AMP, theophylline, cholinergic agents and colchicine on clot retraction in dilute platelet-rich plasma and gel-separated platelet test systems.
    Moake JL; Cimo PL; Widmer K; Peterson DM; Gum JR
    Thromb Haemost; 1977 Aug; 38(2):420-8. PubMed ID: 202038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.